Yüklüyor......
Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases
INTRODUCTION: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, correlates with cardiovascular risk especially in patients with chronic kidney disease. The aim of our study was to establish significance of ADMA as a biomarker of arterial damage in children with gl...
Kaydedildi:
| Yayımlandı: | Cent Eur J Immunol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Termedia Publishing House
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7050061/ https://ncbi.nlm.nih.gov/pubmed/32140048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2019.92788 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|